Rev.eye.talise Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Rev.eye.talise General Information
Description
Developer of micro-surgical robotics intended to deliver regenerative therapies. The company's technology uses flexible robotic systems with wrist-like dexterity and AI-assisted image analysis, enabling surgeons to perform precise tissue manipulation and targeted delivery of therapies within the human retina.
Contact Information
Corporate Office
- London
- England, United Kingdom
Corporate Office
- London
- England, United Kingdom
Rev.eye.talise Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 30-Sep-2022 | Completed | Startup |
Rev.eye.talise Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| King's20 Accelerator | Accelerator/Incubator |
Rev.eye.talise FAQs
-
Where is Rev.eye.talise headquartered?
Rev.eye.talise is headquartered in London, United Kingdom.
-
What industry is Rev.eye.talise in?
Rev.eye.talise’s primary industry is Drug Delivery.
-
Is Rev.eye.talise a private or public company?
Rev.eye.talise is a Private company.
-
What is Rev.eye.talise’s current revenue?
The current revenue for Rev.eye.talise is .
-
Who are Rev.eye.talise’s investors?
King's20 Accelerator has invested in Rev.eye.talise.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process